Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 5 Multiple Myeloma 4 Barrett Esophagus 3 Venous Thromboembolism 2 Tobacco Use Disorder 2 Prostatic Neoplasms 2 Precancerous Conditions 2 Polycythemia Vera 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Vascular Diseases 1 Triple Negative Breast Neoplasms 1 Thromboembolism 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stroke 1 Soft Tissue Neoplasms 1 Smoking Cessation 1 Sarcoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Pulmonary Nodules 1

Interventions

Nutrition Assessment 2 Rosuvastatin Calcium 1 Resistance Training 1 Enoxaparin 1 Cholecalciferol 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Stroke × Aspirin × Clear all

NCT01763606 2020-08-14

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Memorial Sloan Kettering Cancer Center

Phase NA Completed

20 enrolled 11 charts

Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡